BlackRock Portfolio Management LLC's 6% Ownership in Verona Pharma PLC
2025-10-17SEC Filing SCHEDULE 13G (0002052113-25-003560)
BlackRock Portfolio Management LLC has reported a 6% ownership in Verona Pharma PLC, holding 27,645,624 shares of common stock. The filing, submitted under Rule 13d-1(b), indicates that BlackRock has sole voting power over 27,645,416 shares and sole dispositive power over all 27,645,624 shares. The shares were acquired and are held in the ordinary course of business, with no intent to influence the control of Verona Pharma PLC. The filing also notes that various persons have the right to receive dividends or proceeds from the sale of the shares, but no single person's interest exceeds 5% of the total outstanding shares.
Tickers mentioned in this filing:VRNA
The link to the original SEC document:https://www.sec.gov/Archives/edgar/data/1657312/0002052113-25-003560.txt